Hong Kong Exchanges and Clearing (HKEX) will launch five new weekly stock options and a Hang Seng Biotech Index Futures contract this month, expanding hedging tools for investors as derivatives trading on the bourse hits record levels, a senior executive said.
The new weekly stock options – tracking CNOOC, China Mobile, AIA Group, Xiaomi and Semiconductor Manufacturing International Corporation (SMIC) – will begin trading on November 10, while the biotech futures contract will debut on November 28.
HKEX’s average daily turnover of equity-derivative contracts rose 7 per cent year on year to 1.54 million in the first nine months of 2025, putting the exchange on track for a third straight record year, according to exchange data.
“The active trading and the introduction of these new products underscore the market’s vibrancy and regional influence of the derivatives market in Hong Kong,” said HKEX senior vice-president David Lutz in a recent media briefing.
Hong Kong became the first Asian market to launch short-term weekly stock options in November 2024, starting with 10 major stocks including Tencent Holdings, HSBC and Alibaba Group Holding, which owns the Post.
Contemporary Amperex Technology Co (CATL) was added in June.
